Hao Wen Holdings Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hao Wen Holdings Limited with three other
pharmaceutical manufacturers in Asia:
sales of 719.20 million Indian Rupees [US$9.76 million]
General Biological Corporation
(239.65 million Taiwanese Dollars [US$8.19 million]
Lyka Labs Limited
based in INDIA
(707.80 million Indian Rupees [US$9.60 million]
Hao Wen Holdings Limited reported sales of HK$71.61 million (US$9.24 million)
December of 2019.
decrease of 19.0%
versus 2018, when the company's sales were HK$88.40 million.
Contributing to the drop in overall sales was the 27.2% decline
in Electronic Parts, from HK$48.80 million to HK$35.51 million.
There were also decreases in sales in
Money Lending (down 8.9% to HK$36.09 million)